Fund Holdings — SUPERSTRING CAPITAL MANAGEMENT LP

Total Portfolio Value:
$79.33M
Total Bought:
$39.17M
Total Sold:
$108.71M
Net Transaction:
-$69.54M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Cytokinetics, Incorporated(CYTK)278,915187,633-91,282$19.55M$10.17M12.81%-$9.39M
Legend Biotech CorporationADS(LEGN)0154,665+154,665$0$6.85M8.64%+$6.85M
Terns Pharmaceuticals Inc0956,542+956,542$0$6.51M8.21%+$6.51M
BridgeBio Pharma, Inc.(BBIO)353,507219,837-133,670$10.93M$5.57M7.02%-$5.36M
89bio Inc941,287680,403-260,884$10.96M$5.45M6.87%-$5.51M
Nkarta, Inc.(NKTX)1,189,193875,999-313,194$12.86M$5.18M6.53%-$7.68M
Zai Lab LimitedADR(ZLAB)0215,178+215,178$0$3.73M4.70%+$3.73M
Keros Therapeutics, Inc.(KROS)33,82874,288+40,460$2.24M$3.39M4.28%+$1.16M
Arcellx Inc
COMMON STOCK
059,133+59,133$0$3.26M4.11%+$3.26M
Arrowhead Pharmaceuticals, Inc.(ARWR)0111,133+111,133$0$2.89M3.64%+$2.89M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)056,468+56,468$0$2.56M3.22%+$2.56M
BeOne Medicines AGADR(ONC)012,508+12,508$0$1.78M2.25%+$1.78M
Fate Therapeutics, Inc.(FATE)920,476497,360-423,116$6.76M$1.63M2.06%-$5.12M
Allogene Therapeutics Inc521,249689,912+168,663$2.33M$1.61M2.03%-$722.5K
Pyxis Oncology, Inc.(PYXS)493,759484,443-9,316$2.10M$1.60M2.02%-$499.9K
Apogee Therapeutics Inc44,86836,928-7,940$2.98M$1.45M1.83%-$1.53M
CytomX Therapeutics, Inc.(CTMX)679,4031,151,518+472,115$1.48M$1.40M1.77%-$76.2K
Newamsterdam Pharma Company
ORDINARY SHARES
064,213+64,213$0$1.23M1.55%+$1.23M
Tourmaline Bio Inc69,97295,229+25,257$1.60M$1.22M1.54%-$377.7K
NovoCure Limited(NVCR)066,892+66,892$0$1.15M1.44%+$1.15M
Spyre Therapeutics, Inc.(SYRE)045,571+45,571$0$1.07M1.35%+$1.07M
Cabaletta Bio, Inc.(CABA)290,797139,895-150,902$4.96M$1.05M1.32%-$3.91M
Tango Therapeutics, Inc.(TNGX)0115,571+115,571$0$991.6K1.25%+$991.6K
Allakos Inc1,233,739940,578-293,161$1.55M$940.6K1.19%-$613.9K
Perspective Therapeutics, Inc.(CATX)087,638+87,638$0$873.8K1.10%+$873.8K
Savara Inc.(SVRA)2,065,144200,000-1,865,144$10.28M$806.0K1.02%-$9.48M
Biomea Fusion, Inc.(BMEA)0167,110+167,110$0$752.0K0.95%+$752.0K
Kura Oncology, Inc.(KURA)036,242+36,242$0$746.2K0.94%+$746.2K
Zura Bio LimitedCL A(ZURA)0156,626+156,626$0$548.2K0.69%+$548.2K
Atyr Pharma Inc0313,028+313,028$0$488.3K0.62%+$488.3K
PepGen Inc.(PEPG)114,38529,249-85,136$1.68M$466.8K0.59%-$1.21M
Karyopharm Therapeutics Inc.(KPTI)0534,485+534,485$0$463.7K0.58%+$463.7K
EyePoint, Inc.(EYPT)037,838+37,838$0$329.2K0.41%+$329.2K
Marinus Pharmaceuticals Inc565,550261,861-303,689$5.11M$306.4K0.39%-$4.81M
Mersana Therapeutics Inc0110,073+110,073$0$221.2K0.28%+$221.2K
Lakeshore Biopharma Co Ltd307,920307,9200$215.5K$199.5K0.25%-$16.0K
COMPASS Pathways plcADS(CMPS)032,497+32,497$0$196.3K0.25%+$196.3K
Syros Pharmaceuticals Inc037,789+37,789$0$195.0K0.25%+$195.0K
Spruce Biosciences Inc440,22577,992-362,233$346.0K$40.4K0.05%-$305.6K
Aerovate Therapeutics Inc110,2640-110,264$3.26M$0—-$3.26M
Alpine Immune Sciences Inc9,0380-9,038$358.3K$0—-$358.3K
Annexon, Inc.(ANNX)155,7280-155,728$1.12M$0—-$1.12M
Ascendis Pharma A/SADR(ASND)12,7540-12,754$1.93M$0—-$1.93M
Aurinia Pharmaceuticals Inc.(AUPH)98,6910-98,691$494.4K$0—-$494.4K
Avidity Biosciences Inc37,0310-37,031$945.0K$0—-$945.0K
Axsome Therapeutics, Inc.(AXSM)36,6070-36,607$2.92M$0—-$2.92M
Day One Biopharmaceuticals I
COM
349,6790-349,679$5.78M$0—-$5.78M
Dyne Therapeutics, Inc.(DYN)99,8220-99,822$2.83M$0—-$2.83M
IDEAYA Biosciences, Inc.(IDYA)217,0700-217,070$9.53M$0—-$9.53M
Inozyme Pharma Inc112,7390-112,739$863.6K$0—-$863.6K
Ionis Pharmaceuticals, Inc.(IONS)120,8960-120,896$5.24M$0—-$5.24M
Kalvista Pharmaceuticals Inc32,0250-32,025$379.8K$0—-$379.8K
Lyra Therapeutics Inc145,2840-145,284$903.7K$0—-$903.7K
Praxis Precision Medicines, Inc.(PRAX)40,1190-40,119$2.45M$0—-$2.45M
Roivant Sciences Ltd.SHS(ROIV)531,0190-531,019$5.60M$0—-$5.60M
So-Young International Inc.ADS(SY)182,7420-182,742$199.2K$0—-$199.2K
UroGen Pharma Ltd.(URGN)288,2670-288,267$4.32M$0—-$4.32M
Verona Pharma PlcADS259,3830-259,383$4.17M$0—-$4.17M
Page 1 of 1